Clinical Trial Update: Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma [Phase 4]

View source ↗

Summary

A multi-center Phase 4 randomized controlled trial is evaluating Shenling Baishu Granule for preventing recurrence of low-risk colorectal adenoma. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma

Drugs mentioned

• Shenling Baishu Granule (Shenling Baishu Granule)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Low-risk Colorectal Adenoma | Phase 4 | Status: RECRUITING